Sermorelin GHRH analog dosing models reviewed: dose-response data, PK comparisons, and mechanistic evidence across pituitary, neuro, and cardiac axes.
Most research peptides fail orally — but a few don’t. Learn the formulation science behind oral capsule delivery and which compounds survive the GI tract.
How to read a peptide Certificate of Analysis — decode purity methods, spot HPLC failure modes, and know exactly what a CoA does and doesn’t confirm.
Oral vs injectable peptides — bioavailability isn’t the whole story. Preclinical data reveals when route of administration actually changes outcomes.
Peptides can’t survive the gut — that was the consensus. Preclinical data from 2020–2026 says the formulation science has caught up.
Where to buy BPC-157 capsules in 2026? The preclinical data on oral bioactivity is compelling — if the sourcing standards hold up. Here’s the checklist.
Hallmarks Stack targets 12 aging mechanisms via 4 orthogonal research compounds. Preclinical evidence mapped across NAD+, MOTS-c, Epithalon & GHK-Cu.
Recomp Stack research: CJC-1295, Tesamorelin, and MOTS-c mechanisms for visceral fat reduction and lean mass. Preclinical data reviewed.
BPC-157 mechanisms, preclinical protocols and stacking research. Complete guide with data tables, named limitations and PubMed citations.
TB-500 and Thymosin Beta-4 preclinical research: ILK-Akt signaling, anti-fibrotic mechanisms, and tissue repair findings across animal models.
THE STACK · RESEARCH NOTES
125 papers across 8 compound categories.